The limitations of traditional cancer treatments are driving the creation and development of
new nanomedicines. At present, with the rapid increase of research on nanomedicine in the …

Liver diseases such as hepatitis, cirrhosis, and hepatocellular carcinoma are global health
problems accounting for approximately 800 million cases and over 2 million deaths per year …

Extracellular vesicles (EVs) have demonstrated unique advantages in serving as
nanocarriers for drug delivery, yet the cargo encapsulation efficiency is far from expectation …

Natural compounds have significant anticancer pharmacological activities, but often suffer
from low bioavailability and selectivity that limit therapeutic use. The present work critically …

The characteristics of the primary tumor blood vessels and the tumor microenvironment drive
the enhanced permeability and retention (EPR) effect, which confers an advantage towards …

Background Natural products can exert promising nutritional and medicinal value, and
traditionally used in pursuit of health and well-being. Despite having a potential therapeutic …

Various cancer therapies have advanced remarkably over the past decade. Unlike the direct
therapeutic targeting of tumor cells, cancer immunotherapy is a new strategy that boosts the …

Chemo-immunotherapy based on immunogenic cell death (ICD) is a promising strategy for
cancer therapy. However, the effective ICD requires a high dosage of ICD stimulus, which …

Liposomes have been attracted considerable attention as phospholipid spherical vesicles,
over the past 40 years. These lipid vesicles are valued in biomedical application due to their …

In an effort to enhance antitumor and anti-metastasis of breast cancer, honokiol (HNK) was
encapsulated into hyaluronic acid (HA) modified cationic liposomes (Lip). The prepared HA …